Literature DB >> 19666034

The inflammatory status of the elderly: the intestinal contribution.

Eduardo J Schiffrin1, John E Morley, Anne Donnet-Hughes, Yves Guigoz.   

Abstract

A common finding in the elderly population is a chronic subclinical inflammatory status that coexists with immune dysfunction. These interconnected processes are of sufficient magnitude to impact health and survival time. In this review we discuss the different signals that may stimulate the inflammatory process in the aging population as well as the molecular and cellular components that can participate in the initiation, the modulation or termination of the said process. A special interest has been devoted to the intestine as a source of signals that can amplify local and systemic inflammation. Sentinel cells in the splanchnic area are normally exposed to more than one stimulus at a given time. In the intestine of the elderly, endogenous molecules produced by the cellular aging process and stress as well as exogenous evolutionarily conserved molecules from bacteria, are integrated into a network of receptors and molecular signalling pathways that result in chronic inflammatory activation. It is thus possible that nutritional interventions which modify the intestinal ecology can diminish the pro-inflammatory effects of the microbiota and thereby reinforce the mucosal barrier or modulate the cellular activation pathways.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666034     DOI: 10.1016/j.mrfmmm.2009.07.011

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  35 in total

Review 1.  Intestinal barrier and gut microbiota: Shaping our immune responses throughout life.

Authors:  Tatiana Takiishi; Camila Ideli Morales Fenero; Niels Olsen Saraiva Câmara
Journal:  Tissue Barriers       Date:  2017-09-28

2.  Clinical Considerations Regarding the Use of Thiopurines in Older Patients with Inflammatory Bowel Disease.

Authors:  Margalida Calafat; Míriam Mañosa; Fiorella Cañete; Eugeni Domènech
Journal:  Drugs Aging       Date:  2021-01-13       Impact factor: 3.923

3.  Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats.

Authors:  W Ren; J Wu; L Li; Y Lu; Y Shao; Y Qi; B Xu; Y He; Y Hu
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C. elegans to mice.

Authors:  Shaohua Wang; Shokouh Ahmadi; Ravinder Nagpal; Shalini Jain; Sidharth P Mishra; Kylie Kavanagh; Xuewei Zhu; Zhan Wang; Donald A McClain; Stephen B Kritchevsky; Dalane W Kitzman; Hariom Yadav
Journal:  Geroscience       Date:  2019-12-08       Impact factor: 7.713

5.  Inflammation and p53: A Tale of Two Stresses.

Authors:  Andrei V Gudkov; Katerina V Gurova; Elena A Komarova
Journal:  Genes Cancer       Date:  2011-04

Review 6.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 7.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

Review 8.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

Review 9.  p53 and the Carcinogenicity of Chronic Inflammation.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 10.  Inflammaging and the Lung.

Authors:  Elizabeth J Kovacs; Devin M Boe; Lisbeth A Boule; Brenda J Curtis
Journal:  Clin Geriatr Med       Date:  2017-07-14       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.